Quantum-Si incorporated

QSI

US74765K1051

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-26 pm EDT			5-day change	1st Jan Change
1.65 ^USD	+2.48%		+5.10%	-17.91%

Mar. 21	Quantum-Si Incorporated Appoints Paula Dowdy to the Board of Directors	CI
Feb. 29	Transcript : Quantum-Si incorporated, Q4 2023 Earnings Call, Feb 29, 2024

Quantum-Si Incorporated Provides Earnings Guidance for the Full Year 2024

February 29, 2024 at 04:17 pm EST

Quantum-Si incorporated provided earnings guidance For the full year 2024. For the year, the Company expects Revenue to be $3.7 million - $4.2 million.

Latest news about Quantum-Si incorporated

Quantum-Si Incorporated Appoints Paula Dowdy to the Board of Directors	Mar. 21	CI
Transcript : Quantum-Si incorporated, Q4 2023 Earnings Call, Feb 29, 2024	Feb. 29
Quantum-Si incorporated Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 29	CI
Quantum-Si Incorporated Provides Earnings Guidance for the Full Year 2024	Feb. 29	CI
Earnings Flash (QSI) QUANTUM-SI INCORPORATED Reports Q4 Revenue $400,000, vs. Street Est of $0.3M	Feb. 29	MT
Quantum-Si incorporated Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 29	CI
Quantum-Si incorporated Expands Proteome Coverage and Increases Sequencing Output with New Enhancements to Its Next-Generation Protein Sequencing? Platform	Feb. 05	CI
Quantum-Si Introduces Next-Generation Protein Sequencertm in Japan with Addition of New Distributor	Jan. 18	CI
Quantum-Si Incorporated Introduces First Next-Generation Protein Sequencer in Japan with Addition of New Distributor, TOMY Digital Biology Co., Ltd	Jan. 18	CI
Quantum-Si incorporated(NasdaqGM:QSI) dropped from NASDAQ Biotechnology Index	Dec. 15	CI
Quantum-Si Incorporated Expands Global Reach with Addition of New Distributor, 3Genes Distribution a.s	Dec. 12	CI
HC Wainwright Initiates Quantum-Si With Buy Rating, Price Target is $3	Dec. 08	MT
Quantum-Si Incorporated Enters into Agreement with Elta 90 to Distribute Quantum-Si?s Groundbreaking Platinum Instrument and Consumables in Southeast Europe	Nov. 15	CI
Earnings Flash (QSI) QUANTUM-SI INCORPORATED Reports Q3 Revenue $223,000, vs. Street Est of $400,000	Nov. 09	MT
Quantum-Si incorporated Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 09	CI
Transcript : Quantum-Si incorporated, Q3 2023 Earnings Call, Nov 09, 2023	Nov. 09
Canaccord Genuity Downgrades Quantum-Si to Hold From Buy, Trims Price Target to $2 From $3.50	23-09-25	MT
Quantum-Si Incorporated Announces Appointment of Amir Jafri to Its Board of Directors	23-09-21	CI
Quantum-Si incorporated Announces Executive Changes	23-08-29	CI
Quantum-Si incorporated Terminates Approximately 16% of its Workforce	23-08-29	CI
Transcript : Quantum-Si incorporated, Q2 2023 Earnings Call, Aug 07, 2023	23-08-07
Earnings Flash (QSI) QUANTUM-SI INCORPORATED Posts Q2 Revenue $205,000, vs. Street Est of $400,000	23-08-07	MT
Quantum-Si incorporated Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-07	CI
Quantum-Si Shares Jump Premarket Monday After Dropping 6.2% in Previous Regular Trading Session	23-07-17	MT
Quantum-Si Incorporated Announces Executive Changes	23-06-21	CI

Quantum-SI Incorporated is a life sciences company. The Company has designed and developed a hardware, consumable and software solution to provide a solution for protein detection and analysis. It has developed a proprietary universal single-molecule detection platform enables Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins. Its launched product consists of Platinum, the Platinum Analysis Software and consumables. Its flagship protein sequencing instrument, Platinum, is designed to make the power of single-molecule detection and NGPS accessible. Platinum is designed to provide a streamlined workflow compared to legacy MS workflows. Platinum uses its proprietary semiconductor chip that leverages time-domain sequencing with an initial focus on NGPS for an unbiased view of the proteome.

Sector

Biotechnology & Medical Research

Calendar

2024-05-08 - Q1 2024 Earnings Release

Related indices

Russell 2000

More about the company

Income Statement Evolution

More financial data

Ratings for Quantum-Si incorporated

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

1.65 USD

Average target price

2.72 USD

Spread / Average Target

+64.85%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
QUANTUM-SI INCORPORATED	-17.91%	234M
IQVIA HOLDINGS INC.	+1.51%	42.75B
LONZA GROUP AG	+49.22%	41.61B
MODERNA, INC.	+8.57%	41.34B
CELLTRION, INC.	-12.36%	26.59B
ICON PUBLIC LIMITED COMPANY	+8.92%	25.49B
ALNYLAM PHARMACEUTICALS, INC.	-25.13%	18.12B
MEDPACE HOLDINGS, INC.	+29.17%	12.24B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-3.12%	11.76B
UNITED THERAPEUTICS CORPORATION	+6.35%	11B

Other Biotechnology & Medical Research